🚀 Mexico Schizophrenia Drugs Market to Reach US$ 196.45 Million by 2033, Driven by Rising Mental Health Awareness
According to Renub Research, the Mexico Schizophrenia Drugs Market is projected to grow from US$ 148.99 million in 2024 to US$ 196.45 million by 2033, expanding at a CAGR of 3.12% from 2025 to 2033. The increasing awareness surrounding mental health, coupled with government initiatives and pharmaceutical innovation, is shaping the landscape of schizophrenia treatment…